Skip to main content
. 2016 Jan 18;8(2):92–106. doi: 10.4254/wjh.v8.i2.92

Figure 1.

Figure 1

Hepatitis C virus replicative cycle and main targets for direct acting antiviral agents. Modified from Manns and Cornberg. Lancet Infectious Diseases 2013. PIs: Protease inhibitors; NPIs: Nucleoside polymerase inhibitors; NNPIs: Non-nucleoside polymerase inhibitors.